China steps up inactivated Covid-19 vaccine development

CNC
Added On June 2, 2020

China National Biotec Group. The bio company says it has two vaccine candidates under Phase-2 clinical trials. More than 2,000 people have received those vaccines and clinical data has verified their safety and efficacy, with far lower adverse reactions than other similar products. The company has also built a large production unit in Beijing with high bio-safety protection standards. The unit is expected to produce more than 100 million COVID-19 vaccines a year once mass production begins.